1. Synthesis and Cytotoxicity of Novel β-Ala-Phthalazine-Based Derivatives as VEGFR2 Inhibitors and Apoptosis-Inducers Against Liver Cancer.
- Author
-
Emam, Sara M., El Rayes, Samir M., Ali, Ibrahim A. I., Soliman, Hamdy A., and Nafie, Mohamed S.
- Subjects
- *
METHYLENE compounds , *CYTOTOXINS , *BINDING energy , *AMINO acids , *LIVER cancer , *PHTHALAZINE - Abstract
AbstractSome novel β-Ala-phthalazine derivatives were synthesized from the parent methyl 3-(2-(4-benzyl-1-oxophthalazin-2(1H)-yl) acetamido)propanoate
(1) . Then, ester1 underwent hydrazinolysis to produce the hydrazide 2-(4-benzyl-1-oxophthalazin-2(1H )-yl)-N -(3-hydrazineyl-3-oxo propyl) acetamide (2 ). Under the azide coupling technique, hydrazide2 formed azide3 which was further coupled with some amines and amino acid esters hydrochloride to produce the corresponding novel dipeptides4a–h and5a–d, respectively. Finally, hydrazide2 was condensed and/or cyclized with some ketones and/or active methylene compounds resulting in the formation of various derivatives6a-e . Compounds2 ,6c , and6d demonstrated significant cytotoxicity, with IC50 values of 1.33, 0.41, and 0.38 μM compared to Sorafenib (IC50 = 2.93 μM). Compounds6d exhibited potent VEGFR2 inhibition by 97.6% with an IC50 value of 21.9 μM compared to Sorafenib (94.7% and IC50 value of 30.1 μM). The6d treatment significantly increased apoptotic activity by 23.6-fold, causing a halt in cell proliferation at the G2/M phase. Ultimately, it exhibited a strong affinity for the VEGFR2 protein, with a binding energy of −26.8 Kcal/mol, and it established binding contacts with the crucial amino acids involved in the interaction. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF